Agenus Inc. (AGEN) vs Mobia Medical, Inc. Common Stock (MOBI)
A side-by-side comparison of Agenus Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$7.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MOBI
Mobia Medical, Inc. Common Stock
$8.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AGEN vs MOBI
growth of $100 · dividends reinvested · last 1yAGEN +124.4% (+124.4%/yr)MOBI -36.1% (-36.1%/yr)AGEN compounded faster over this window
AGEN MOBI
AGEN vs MOBI: by the numbers
- •AGEN is the larger company ($312M vs $293M market cap).
- •AGEN is profitable (69.34% net margin) while MOBI runs a net loss (-145.12%).
Metrics side by side
Valuation
| Metric | AGEN | MOBI |
|---|---|---|
| P/E ratio | 2.83 | N/A |
| Forward P/E | 28.00 | N/A |
| P/S ratio | 2.35 | N/A |
| P/B ratio | N/A | 1.70 |
| EV / EBITDA | 8.16 | N/A |
Profitability
| Metric | AGEN | MOBI |
|---|---|---|
| Gross margin | 29.63% | 81.07% |
| Operating margin | -18.00% | -144.71% |
| Net margin | 69.34% | -145.12% |
| ROIC | N/A | -122.21% |
Growth (annualized)
| Metric | AGEN | MOBI |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | N/A |
| Total return CAGR (5Y) | -40.10% | N/A |
Frequently asked
- Is AGEN or MOBI more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus MOBI at -145.12%.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROEMobia Medical, Inc. Common Stock ROEAgenus operating marginMobia Medical, Inc. Common Stock operating marginAgenus revenue growthMobia Medical, Inc. Common Stock revenue growthAgenus free cash flowMobia Medical, Inc. Common Stock free cash flow
Agenus & Mobia Medical, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.